Description: Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel, oral antivirals to address unmet medical needs in the United States. Its lead compounds include brincidofovir (CMX001), which is in Phase III clinical development; CMX157, a nucleotide analog that has completed Phase I study for the treatment of HIV infections. The company?s proprietary lipid technology and chemical library is under discovery and preclinical stage of development. It has collaboration and license agreement with Merck Sharp & Dohme Corp. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.

Follow us

Copyright

We are constantly working on our website improvements. We need your help. Please give us some feedback by completing this short poll. It will only take a few minutes of your time but it means a lot to us.

What type of instruments do you invest in?

Forex

Stocks

ETFs

Future contracts

Options

Do you consider using trends when making investment decisions?

All the time

Very often

From time to time

Almost never

Not at all

Other

Do you consider the tools provided by our site helpful for your trading activities?

All the time

Very often

From time to time

Almost never

Not at all

Other

Do you find the our website easy-to-use when you look for specific information?

All the time

Very often

From time to time

Almost never

Not at all

Other

Do you use other stock market screeners?

All the time

Very often

From time to time

Almost never

Not at all

Other

What would you change about our website graphical design?

Do you understand how to use our tools, if not what can we do to improve that?

If you have any more comments e.g. what to add, any mistakes you came across etc. please share it with us.